CClinicalTrials.gg
CompletedNCT05260138Updated Mar 2, 2022

Bundling Gentle Body Massage Along With Regular Position Change Under Phototherapy

An interventional study of Gentle Body message and Routine NICU Care in Hyperbilirubinemia, Neonatal, sponsored by Alexandria University. Completed at 1 site in Egypt. Open to participants aged 1 Day to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-02.

Sponsored by Alexandria University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Aug 2021, registered Feb 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Day to 28 Days
Sex
All
01

Study summary

This study aimed to investigate the effect of bundling gentle body massage along with regular position change on bilirubin level and clinical outcomes among full-term neonates with hyperbilirubinemia under phototherapy.

Hypothesis

Full-term neonates with hyperbilirubinemia who receive gentle body massage along with regular position change exhibit less bilirubin level and better clinical outcomes than those who don't.

Read the detailed description

A quasi-experimental study was carried out in the NICU of XX. Sixty full-term neonates were randomly assigned to two equal groups.

The control group received the conventional NICU care of infants undergoing phototherapy. Phototherapy was given by single Blue LEDs emitting light in a narrow spectrum (450-470 nm). Initially, phototherapy lamps were checked and adjusted at the height of 30 cm from the neonates who were kept naked in the incubator/crib except for the reproductive organs with shielded eyes. The neonates were positioned supine under the phototherapy. The treatment was given continuously, except while feeding and nursing for 30 minutes every 3 hours. The neonates' skin was cleaned with warm water without applying any sorts of ointments oils or creams. They were also observed for signs of dehydration.

The intervention group received all basic routine care in addition to regular position change from supine to laterals under the phototherapy every two hours. They also received gentle body massage

02

Conditions studied

  • Hyperbilirubinemia, Neonatal

Keywords

  • Hyperbilirubinemia
  • neonatal
  • Massage Therapy
  • Bilirubin
  • Stool frequency
  • Length of Hospital Stay
03

In context

Hyperbilirubinemia, Neonatal

93 studies on the registry are indexed under Hyperbilirubinemia, Neonatal; 20 are open to participants now.

This study's enrollment of 60 is below the median of 94 across 59 interventional studies indexed under Hyperbilirubinemia, Neonatal.

Browse Hyperbilirubinemia, Neonatal studies →

Lead sponsor

Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Full-term
  • receive enteral feeding (breast, bottle, or mixed feeding, gavage)
  • Newly admitted

Exclusion criteria

Exclusion Criteria:

  • Required exchange transfusion
  • Required mechanical ventilation
  • Has acute phase of circulatory insufficiency
  • Hemolytic disease
  • Neurological disorders
  • Congenital anomalies
  • Neonatal sepsis Diarrhea
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    The intervention group

    received all basic routine care in addition to regular position change and gentle body massage

    Other: Gentle Body message

  • Active comparator
    The control group

    received the conventional NICU care

    Other: Routine NICU Care

Interventions

  • OtherGentle Body message

    The intervention group received gentle body massage twice/day and position change from supine to lateral every two hours under the phototherapy for three consecutive days in addition to routine NICU care.

  • OtherRoutine NICU Care

    received the conventional NICU care of infants undergoing phototherapy. Phototherapy was given by single Blue LEDs emitting light in a narrow spectrum (450-470 nm). Initially, phototherapy lamps were checked and adjusted at the height of 30 cm from the neonates who were kept naked in the incubator/crib except for the reproductive organs with shielded eyes. The neonates were positioned supine under the phototherapy. The treatment was given continuously, except while feeding and nursing for 30 minutes every 3 hours. The neonates' skin was cleaned with warm water without applying any sorts of ointments oils or creams. They were also observed for signs of dehydration.

06

What researchers measure

Primary outcomes

  1. Bilirubin level

    The researchers recorded the neonates' Bilirubin level from the laboratory results

    Time frame: After 3 days

Secondary outcomes

  1. Percentage of the consumed milk

    The researchers calculated the percentage of the consumed milk by dividing the actual amount sucked by the neonate on the prescribed amount and multiplied by 100

    Time frame: After 3 days

  2. Frequency of stool

    The researchers counted number of neonates' stool passage per day

    Time frame: After 3 days

  3. daily weight

    The researchers measured the neonates' weight daily using the same scale

    Time frame: After 3 days

  4. Length of hospital stay

    the researchers obtained the neonates' length of hospital stay from admission to discharge

    Time frame: After 10 days

07

Study locations

1 site
  • Faculty of Nursing
    Alexandria, 56321, Egypt
08

References and documents

Publications

  • Zhang M, Wang L, Wang Y, Tang J. The influence of massage on neonatal hyperbilirubinemia: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2019 Sep;32(18):3109-3114. doi: 10.1080/14767058.2018.1455183. Epub 2018 Apr 9. PubMed 29631455 ↗
  • Chen A, Du L, Xu Y, Chen L, Wu Y. The effect of blue light exposure on the expression of circadian genes: bmal1 and cryptochrome 1 in peripheral blood mononuclear cells of jaundiced neonates. Pediatr Res. 2005 Dec;58(6):1180-4. doi: 10.1203/01.pdr.0000183663.98446.05. PubMed 16306190 ↗
  • Donneborg ML, Knudsen KB, Ebbesen F. Effect of infants' position on serum bilirubin level during conventional phototherapy. Acta Paediatr. 2010 Aug;99(8):1131-4. doi: 10.1111/j.1651-2227.2010.01885.x. Epub 2010 Jun 2. PubMed 20528799 ↗
  • Field TM, Schanberg SM, Scafidi F, Bauer CR, Vega-Lahr N, Garcia R, Nystrom J, Kuhn CM. Tactile/kinesthetic stimulation effects on preterm neonates. Pediatrics. 1986 May;77(5):654-8. PubMed 3754633 ↗
  • Kato S, Iwata O, Yamada Y, Kakita H, Yamada T, Nakashima H, Sugiura T, Suzuki S, Togari H. Standardization of phototherapy for neonatal hyperbilirubinemia using multiple-wavelength irradiance integration. Pediatr Neonatol. 2020 Feb;61(1):100-105. doi: 10.1016/j.pedneo.2019.07.002. Epub 2019 Aug 12. PubMed 31473126 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05260138
Lead sponsor
Alexandria University
Responsible party
Zohour Ibrahim Mahmoud Rashwan (Lecturer, Alexandria University) — Principal investigator
First posted
Mar 2, 2022
Start date
Aug 20, 2021
Primary completion
Dec 17, 2021
Completion
Dec 18, 2021
Last update
Mar 2, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion